Ma Chun K K, Danta Mark, Day Richard, Ma David D F
Department of Haematology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Intern Med J. 2018 Jan;48(1):16-24. doi: 10.1111/imj.13652.
Escalating cost of medicines is rapidly becoming a serious threat to patients and health systems. This trend has been documented to impact patient outcomes adversely. As clinicians and tax payers, it is our responsibility to be aware of the potential detrimental effects spiralling costs have on our patients, our community and our health system and to mitigate these effects by exposing this issue to our respective professional societies, representatives of the pharmaceutical companies that we interact with, government regulatory bodies and to patients who we are caring for. Only through understanding and constructive actions will we be able to provide the best quality of care to our patients and continue to enjoy universal healthcare in our country.
药品成本不断攀升正迅速成为对患者和卫生系统的严重威胁。这一趋势已被证明会对患者治疗结果产生不利影响。作为临床医生和纳税人,我们有责任意识到成本螺旋式上升对我们的患者、社区和卫生系统可能产生的有害影响,并通过将这个问题告知我们各自的专业协会、我们与之互动的制药公司代表、政府监管机构以及我们所照顾的患者来减轻这些影响。只有通过理解和建设性行动,我们才能为患者提供最高质量的护理,并在我国继续享受全民医疗保健。